PharmaceuticalsaAdvances in Research and Application: 2012 Edition is a ScholarlyEditionsac eBook that delivers timely, authoritative, and comprehensive information about Pharmaceuticals. The editors have built PharmaceuticalsaAdvances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.ac You can expect the information about Pharmaceuticals in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of PharmaceuticalsaAdvances in Research and Application: 2012 Edition has been produced by the worldas leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditionsac and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.(2012 FEB 7) Samsung Medical Center, Seoul: Prescription pattern of oxybutynin ER in patients with overactive ... Most were also prescribed 5 (19.1%) or 10 (67.4 %) mg/day at the end of treatment, with a dose escalation rate of 14.9%.
|Title||:||Pharmaceuticals—Advances in Research and Application: 2012 Edition|
|Publisher||:||ScholarlyEditions - 2012-12-26|